What will Clinical Trials look like in 10 years? Experts forecast 3 key trends,
3 October 2019
Adam Berman and Kelsey Jakee, life sciences experts at PA Consulting, discuss the future of clinical trials and share key insights from PA's “Transforming the clinical trial to help us live our best lives” report.
Why a hybrid approach is best for BPMS implementations,
12 September 2019
PA Consulting life sciences expert John Heid explains how pharma companies can use business process management software to automate workflows, enforce data consistency, and lay the groundwork for further AI/automation efforts.
Virtual patient registries: Real-world evidence for cell and gene therapies,
31 May 2019
Sarah Blunt, life sciences expert at PA Consulting, writes that virtual registries can be run at a fraction of the cost of traditional approaches and will enhance patient engagement.
Four approaches to data access strategy — and how to apply them throughout drug development,
14 May 2019
Jamie Cartland and Philip Winkworth, life sciences experts at PA Consulting, highlight four distinct approaches forward-thinking companies are employing to enhance their data access strategies.
Follow the Leader: Why clinical development must transition from pharma-led to patient-led,
13 March 2019
Philip Winkworth and Kelsey Jakee, life sciences experts at PA Consulting, explain how pharma companies can embed new, patient-led clinical development approaches.
6 ways AI Is transforming the Life Sciences (already),
31 January 2019
Rupen Mehta and Stephen Morehouse, life sciences experts at PA Consulting, discuss ways the life sciences industry can use AI effectively to accelerate products to market.
Cardiac stem cell controversy — 3 important lessons learned,
6 December 2018
Sarah Blunt, life sciences expert at PA Consulting, shares three important lessons that can be applied across the field of stem cell research.
4 Barriers to cell and gene therapy development for rare diseases — and how to overcome them,
27 September 2018
Ben Solaski and Perry Yin, life sciences experts at PA Consulting, highlight four challenges that hinder the development of cell and gene therapies to treat rare diseases.
4 Future scenarios for cell and gene therapy adoption,
8 August 2018
Perry Yin, life sciences expert at PA Consulting Group, outlines 4 FutureWorlds scenarios for cell and gene therapy adoption.
5 keys to unlock the full potential of big data in the life sciences,
20 June 2018
Neil Saward, Chris Isler, and Mariko O’Neill, life sciences experts at PA Consulting Group, share insights on how life sciences companies can unlock the full potential of data and technology.